Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    The Value of axitinib in combination with Immuno-oncology (IO) in Patients with Metastatic Renal Cell Carcinoma (mRCC)
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology China
    Innovative Digital Health Projects to increase the Quality of Life (QoL) of Multiple Myeloma (MM) patients
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Oncology Italy
    2024 RD Global Monitoring anti-TFPI RES
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    Call for Independent Medical Education Grant Applications Oncology – Urothelial Carcinoma (UC)
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology All
    Health Services Research to Improve Management of mBC Patients Treated with Tucatinib
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology All
    Addressing Multiple Myeloma Gaps in Care for Patients in Latin America
    Release Date:
    Partner: International Myeloma Foundation
    Review Process: Expert Review Panel
    Education Oncology Argentina, Brazil, Colombia, Mexico
    Providing Appropriate Medical Care for IBD Patients
    Release Date:
    Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Inflammation & Immunology Japan
    Management of Atopic Dermatitis / Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Closing Knowledge Gaps in Transthyretin Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Transthyretin Cardiac Amyloidosis Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Rare Disease USA
    Shared Decision Making Including Financial Cost and Cancer Treatment
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Biomarker Testing / Lung Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Employment Support / Lung Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Epidemiology of Atopic Dermatitis, Alopecia Areata and Vitiligo Needs Assessment (Asia, Latin America, the Middle East & Africa)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology All
    PCF-Pfizer Health Equity Challenge Awards
    Release Date:
    Partner: Prostate Cancer Foundation
    Review Process: Expert Review Panel
    Research Oncology All
    Early Identification and Diagnosis of Axial Spondyloarthritis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    BRAF-mutant melanoma: treatment selection and side effect management
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Canada, USA
    Education for Improving Appropriate Diagnosis and Treatment for Venous Thromboembolism
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Establishment of System for Early Detection of Atrial Fibrillation and Prevention of Cardiogenic Embolism
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine Japan